Your browser doesn't support javascript.
loading
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
Huang, Can; Li, Na-Mei; Gao, Pei; Yang, Sa; Ning, Qian; Huang, Wen; Li, Zhi-Ping; Ye, Peng-Ju; Xiang, Li; He, Dong-Xiu; Tan, Xiang-Wen; Yu, Cui-Yun.
Afiliação
  • Huang C; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Li NM; b Learning Key Laboratory for Pharmacoproteomics of Hunan Province, Institute of Pharmacy & Pharmacology University of South China , Hengyang , China , and.
  • Gao P; c Chemistry Department, Eastern Kentucky University , Richmond , KY , USA.
  • Yang S; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Ning Q; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Huang W; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Li ZP; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Ye PJ; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Xiang L; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • He DX; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Tan XW; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
  • Yu CY; a Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang , China.
Drug Deliv ; 24(1): 459-466, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28219253
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Pró-Fármacos / Carcinoma Hepatocelular / Quitosana / Nanopartículas / Fluoruracila / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Idioma: En Revista: Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Pró-Fármacos / Carcinoma Hepatocelular / Quitosana / Nanopartículas / Fluoruracila / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Idioma: En Revista: Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China